Gregory A. Kopia

785 total citations
33 papers, 629 citations indexed

About

Gregory A. Kopia is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gregory A. Kopia has authored 33 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gregory A. Kopia's work include Coronary Interventions and Diagnostics (11 papers), Nitric Oxide and Endothelin Effects (6 papers) and Cardiac Valve Diseases and Treatments (5 papers). Gregory A. Kopia is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Nitric Oxide and Endothelin Effects (6 papers) and Cardiac Valve Diseases and Treatments (5 papers). Gregory A. Kopia collaborates with scholars based in United States, Netherlands and United Kingdom. Gregory A. Kopia's co-authors include John F. Dooley, Elazer R. Edelman, Brinda Balakrishnan, Robert Ruffolo, Richard E. Valocik, Robert Falotico, Gerard R. Llanos, George Papandreou, Brett Sasseen and Bruce D. Klugherz and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Controlled Release and The American Journal of Medicine.

In The Last Decade

Gregory A. Kopia

33 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory A. Kopia United States	14	370	245	160	83	53	33	629
Peter Markham United States	15	285 0.8×	316 1.3×	175 1.1×	280 3.4×	68 1.3×	38	922
Tarek Ahmed Egypt	10	293 0.8×	226 0.9×	100 0.6×	105 1.3×	96 1.8×	30	554
Brett G. Zani United States	13	257 0.7×	169 0.7×	157 1.0×	70 0.8×	35 0.7×	24	538
Hiroki Ito Japan	15	153 0.4×	244 1.0×	195 1.2×	204 2.5×	70 1.3×	60	740
Giuseppe Andolina Italy	10	344 0.9×	299 1.2×	156 1.0×	37 0.4×	153 2.9×	32	568
S. Lehoux Canada	7	154 0.4×	121 0.5×	159 1.0×	157 1.9×	22 0.4×	10	597
Nina Klingman United States	10	182 0.5×	100 0.4×	189 1.2×	65 0.8×	31 0.6×	16	523
Timothy N. Bachman United States	12	124 0.3×	231 0.9×	220 1.4×	57 0.7×	12 0.2×	25	498
Motokazu Hori Japan	13	237 0.6×	234 1.0×	125 0.8×	30 0.4×	58 1.1×	62	604
John J. Pacella United States	16	196 0.5×	154 0.6×	78 0.5×	57 0.7×	141 2.7×	48	791

Countries citing papers authored by Gregory A. Kopia

Since Specialization

Citations

This map shows the geographic impact of Gregory A. Kopia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Kopia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Kopia more than expected).

Fields of papers citing papers by Gregory A. Kopia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Kopia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Kopia. The network helps show where Gregory A. Kopia may publish in the future.

Co-authorship network of co-authors of Gregory A. Kopia

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory A. Kopia. A scholar is included among the top collaborators of Gregory A. Kopia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory A. Kopia. Gregory A. Kopia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zani, Brett G., James R. L. Stanley, Alison Hayward, et al.. (2017). Biocompatibility, bone healing, and safety evaluation in rabbits with an IlluminOss bone stabilization system. Journal of Orthopaedic Research®. 35(10). 2181–2190. 10 indexed citations

Stanley, James R. L., Abraham R. Tzafriri, Kathryn Regan, et al.. (2016). Particulates from hydrophilic-coated guiding sheaths embolise to the brain. EuroIntervention. 11(12). 1435–1441. 19 indexed citations

Costa, J. Ribamar, et al.. (2012). TCT-572 One-Year Preclinical Data on a Novel Drug-Eluting Stent with Amino Acid-Based Bioabsorbable Drug Carrier Mounted on an Integrated Delivery System (IDS). Journal of the American College of Cardiology. 60(17). B166–B166. 1 indexed citations

Diletti, Roberto, Héctor M. García‐García, Robert‐Jan van Geuns, et al.. (2012). Angiographic and histological results following implantation of a novel stent-on-a-wire in the animal model. EuroIntervention. 8(3). 390–399. 4 indexed citations

Sarno, Giovanna, Takayuki Okamura, Josep Gómez‐Lara, et al.. (2010). The coronary Stent-On-A-Wire (SOAW). EuroIntervention. 6(3). 413–417. 4 indexed citations

Balakrishnan, Brinda, John F. Dooley, Gregory A. Kopia, & Elazer R. Edelman. (2008). Thrombus causes fluctuations in arterial drug delivery from intravascular stents. Journal of Controlled Release. 131(3). 173–180. 38 indexed citations

Balakrishnan, Brinda, John F. Dooley, Gregory A. Kopia, & Elazer R. Edelman. (2007). Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. Journal of Controlled Release. 123(2). 100–108. 93 indexed citations

Levy, Elad I., Ricardó A. Hanel, Fermin O. Tio, et al.. (2006). Safety and Pharmacokinetics of Sirolimus-eluting Stents in the Canine Cerebral Vasculature: 180 Day Assessment. Neurosurgery. 59(4). 925–934. 17 indexed citations

Vetrovec, George W., et al.. (2005). Sirolimus PK trial: A pharmacokinetic study of the sirolimus‐eluting Bx Velocity stent in patients with de novo coronary lesions. Catheterization and Cardiovascular Interventions. 67(1). 32–37. 51 indexed citations

10.

Carter, Andrew J., Wei Wei, R. G. Collingwood, et al.. (2005). Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model. Cardiovascular revascularization medicine. 6(2). 58–64. 8 indexed citations

11.

Ikeno, Fumiaki, et al.. (2004). 1139-49 Sirolimus-eluting stents: Pharmacokinetics in blood, vessel, and myocardium in a porcine coronary model. Journal of the American College of Cardiology. 43(5). A83–A83. 6 indexed citations

12.

Kipshidze, Nicholas, Martin B. Leon, Mykola Tsapenko, et al.. (2004). Update on Sirolimus Drug-Eluting Stents. Current Pharmaceutical Design. 10(4). 337–348. 17 indexed citations

13.

Kopia, Gregory A. & Richard E. Valocik. (1989). Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.. Journal of Pharmacology and Experimental Therapeutics. 248(1). 215–221. 20 indexed citations

14.

Griswold, D.E., et al.. (1989). Evaluation of the effect of Evan's blue and triphenyltetrazolium chloride dyes on myeloperoxidase activity in canine cardiac tissue. Journal of Pharmacological Methods. 21(1). 13–19. 24 indexed citations

15.

Kopia, Gregory A., et al.. (1989). Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.. Journal of Pharmacology and Experimental Therapeutics. 250(3). 887–895. 3 indexed citations

16.

Ohlstein, Eliot H., et al.. (1988). Effects of the thromboxane receptor antagonist SK&F 88046 in the canine, monkey and human coronary vasculature. Prostaglandins. 36(1). 69–84. 10 indexed citations

17.

Kopia, Gregory A., et al.. (1988). Evaluation of the Acute Hemodynamic Effects and Pharmacokinetics of Coronary Thrombolysis Produced by Intravenous Tissue-Type Plasminogen Activator in the Anesthetized Dog. Journal of Cardiovascular Pharmacology. 12(3). 308–316. 5 indexed citations

18.

Kopia, Gregory A., Eliot H. Ohlstein, & Robert Ruffolo. (1988). Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.. Journal of Pharmacology and Experimental Therapeutics. 246(2). 434–440. 3 indexed citations

19.

Kopia, Gregory A., et al.. (1988). Coronary thrombolysis with intravenous streptokinase in the anesthetized dog: a dose-response study.. Journal of Pharmacology and Experimental Therapeutics. 244(3). 956–962. 9 indexed citations

20.

Ruffolo, Robert & Gregory A. Kopia. (1986). Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure. The American Journal of Medicine. 80(2). 67–72. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact